IVZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the provided data, Invesco Ltd (IVZ) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. While there are some positive catalysts such as healthy long-term inflows and analyst upgrades, the company's recent financial performance, hedge fund selling, and lack of strong proprietary trading signals suggest a cautious approach. Holding the stock for now is recommended until more favorable conditions emerge.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is at 26.866, which is neutral but close to oversold territory. The stock is trading near its S1 support level of 24.648, with resistance levels at 26.974 and 27.693. Moving averages are converging, showing no clear trend.
Analysts have raised price targets following Q4 earnings beat.
Net long-term inflows remain healthy at $19.1B over 10 consecutive quarters.
Potential for margin expansion and improved organic growth outlook.
Hedge funds are aggressively selling, with a 14710.43% increase in selling over the last quarter.
Financial performance in Q4 2025 showed a significant decline in net income (-666.75% YoY) and EPS (-671.74% YoY).
No recent news or event-driven catalysts to support a strong buy case.
In Q4 2025, revenue increased by 6.24% YoY to $1.13B. However, net income dropped significantly to -$1.186B (-666.75% YoY), and EPS fell to -2.63 (-671.74% YoY). Gross margin remained flat at 0%. The financials indicate significant challenges despite revenue growth.
Analyst sentiment is mixed but leans slightly positive. Several firms have raised price targets, with TD Cowen and Argus maintaining Buy ratings. However, some firms like BofA and Morgan Stanley have lowered price targets and EPS estimates, citing higher costs and distribution fees.
